SICAGENBSESicagen India LtdHighPositive
Announced Wed, 13 May · 18:16 IST

The Board of Directors in their meeting held on 13.05.2026 has recommended the equity dividend @ 10% (Re. 1.00 per share) on the equity capital of the Company for the FY 2025-26.

SICAGEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.3%1-day move
₹54.00
prior close
₹54.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.3+1.5+1.3-0.3+0.3-2.1-4.6-3.1-2.1+2.8+3.3+0.3-4.0
Up moveDown movePending
AI summary

Sicagen India Ltd's Board meeting on May 13, 2026 approved the audited financial results (standalone & consolidated) for Q4 and FY ended March 31, 2026. The auditors issued an unmodified (clean) opinion on both sets of results. The Board recommended an equity dividend of 10% (Rs. 1 per share) for FY 2025-26, subject to shareholder approval at the 22nd AGM. In leadership changes, Mr. Prasanna Joshi was appointed as Additional Director and Whole-time Director for 3 years, succeeding Mr. Nandakumar Varma who resigned for personal reasons. Mr. K R Jaikumar was designated as Senior Management Personnel. M/s. Venkatesh & Co. was appointed as Internal Auditor and M/s. J. Karthikeyan & Associates was reappointed as Cost Auditor for FY 2026-27.

Likely market impact

The clean audit opinion confirms no material concerns in financial reporting. The modest Rs. 1 per share dividend signals stable cash generation but offers limited upside. Director and auditor changes appear procedural and do not indicate operational distress.